The rule also extends to medically important biologic products.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
In conjunction with the proposed rule, the FDA has sent Congress a plan for improving the FDA’s ability to react in response to drug shortages.
The FDA will accept comments on the rule until Jan. 3, and comments on the information collection requirements until Dec. 4.
More Articles on Quality:
Patient Safety Tool: Medication Error Reduction Scorecards
7 Findings on Patient-Controlled Analgesia Practices
10 Most Popular Patient Safety Tools Oct. 28 to Nov. 1, 2013
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
